Photo from wikipedia
Liver biopsy is recommended in the majority of patients with chronic viral hepatitis for fibrosis evaluation. Because of the potential risks of liver biopsy, many studies related to non‐invasive biomarkers… Click to show full abstract
Liver biopsy is recommended in the majority of patients with chronic viral hepatitis for fibrosis evaluation. Because of the potential risks of liver biopsy, many studies related to non‐invasive biomarkers of hepatic fibrosis have been performed. We aimed to assess the diagnostic value of serum biglycan as a non‐invasive fibrosis marker in chronic hepatitis B patients.
Keywords:
serum biglycan;
fibrosis;
hepatitis;
fibrosis marker;
patients chronic;
chronic hepatitis
Journal Title: Journal of Clinical Laboratory Analysis
Year Published: 2017
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Journal of Clinical Laboratory Analysis
Year Published: 2017
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!